Serine protease inhibitors and human wellbeing interplay: new insights for old friends

PeerJ. 2019 Aug 30:7:e7224. doi: 10.7717/peerj.7224. eCollection 2019.

Abstract

Serine Protease Inhibitors (Serpins) control tightly regulated physiological processes and their dysfunction is associated to various diseases. Thus, increasing interest is given to these proteins as new therapeutic targets. Several studies provided functional and structural data about human serpins. By comparison, only little knowledge regarding bacterial serpins exists. Through the emergence of metagenomic studies, many bacterial serpins were identified from numerous ecological niches including the human gut microbiota. The origin, distribution and function of these proteins remain to be established. In this report, we shed light on the key role of human and bacterial serpins in health and disease. Moreover, we analyze their function, phylogeny and ecological distribution. This review highlights the potential use of bacterial serpins to set out new therapeutic approaches.

Keywords: Disease; Function; Homeostasis; Human gut microbiota; Serine protease inhibitors.

Grants and funding

This work received funding from the Microbiology and the Food Chain division (MICA) of the INRA institute through the metaprogramme MEM - Meta-omics and microbial ecosystems, two ANR projects SerpinGuTarget and Titan and the CMCU-PHC Utique (n°19G0819) - Campus France (41786NC). This work was supported by the SerpinGuTarget (Contract number ANR-14-CE16-0018) and Titan (Contract number ANR-18-CE18-0019-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.